Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00286611 · ClinicalTrials.gov registry record
Determination of Amifostine Levels During Radiation Therapy
A clinical trial, sponsored by University of Iowa.
- Completed
- Registry status
- 13
- Enrollment target
NCT00286611: Completed study, sponsored by University of Iowa.
NCT00286611 is a clinical trial that has completed, run by University of Iowa. The registered enrollment target is 13 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00286611 has completed, sponsored by University of Iowa.
- COMPLETED
- Registry status
- 13 participants
- Enrollment target
Study Summary
Currently, there are no published methods for easily determining the level of amifostine in the blood or saliva. A method has been developed within the Department of Radiation Oncology by Drs. Douglas Spitz and Gurminder Sidhu, within the Spitz Lab. This method has been tested using both animal sampling and expired blood (obtained from DeGowin blood center) mixed with amifostine. If the method proves successful, it could then be used as a tool to quantify blood and salivary amifostine levels and possibly correlate them to treatment efficacy or limiting adverse events using amifostine. A better method of treatment, either increasing the efficacy of amifostine or reducing its unwanted side effects, could then be developed.
Interventions
- PROCEDURE Blood and salivary sampling of amifostine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 13 participants |
| Start Date | 2004-10 |
| Est. Completion | 2008-05 |
What the finished NCT00286611 record still lists
NCT00286611 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 13 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Blood and salivary sampling of amifostine is the first listed.
NCT00286611 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00286611 about?
NCT00286611 is a clinical study titled "Determination of Amifostine Levels During Radiation Therapy". Currently, there are no published methods for easily determining the level of amifostine in the blood or saliva. A method has been developed within the Department of Radiation Oncology by Drs. Douglas Spitz and Gurminder Sidhu, within the Spitz Lab. This method has been tested using both animal samp...
What is the current status of trial NCT00286611?
This trial is currently completed. The enrollment target is 13 participants. The study started on 2004-10. Estimated completion is 2008-05.
What interventions are being tested in trial NCT00286611?
The interventions under investigation include: Blood and salivary sampling of amifostine (PROCEDURE).
Who is sponsoring clinical trial NCT00286611?
This trial is sponsored by University of Iowa, which has 228 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03125655 · 13 participants
Regulation of Inflammatory Genes in Psoriasis
- NCT03774446 · 13 participants · Phase 2
Multicenter Study of Seliciclib (R-roscovitine) for Cushing Disease
- NCT03830151 · 13 participants · Phase 1
Hyperpolarized Carbon C 13 Pyruvate in Diagnosing Glioma in Patients With Brain Tumors
- NCT04573231 · 13 participants · Phase 2
Evaluation of PSMA in HER2- AR+ Metastatic Breast Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia